Search Results 41-50 of 19194 for Lateral

  1. Experimental Antisense Oligonucleotide Treatment for Amyotrophic Lateral Sclerosis With an arg15leu Pathogenic Variant in CHCHD10. - Mayo Clinic

    Experimental Antisense Oligonucleotide Treatment for Amyotrophic Lateral Sclerosis With an arg15leu Pathogenic Variant in CHCHD10. Print details. Share ...

  2. Pridopidine in Amyotrophic Lateral Sclerosis (EAP 2) - Mayo Clinic

    The purpose of this study is to provide access to the investigational product, pridopidine, for up to 200 participants with ALS who are ineligible for clinical ...

  3. Diaphragm Pacing System (DPS) in Participants with Amyotrophic Lateral Sclerosis (ALS) - Mayo Clinic

    Diaphragm Pacing System (DPS) in Participants with Amyotrophic Lateral Sclerosis (ALS) · Overview · Participation eligibility · Participating Mayo Clinic locations.

  4. Tennis elbow - Diagnosis and treatment - Mayo Clinic

    Lateral elbow tendinopathy (lateral epicondylitis). Mayo Clinic; 2022 ... https://orthoinfo.aaos.org/en/diseases--conditions/tennis-elbow-lateral-epicondylitis.

  5. Phase 2 Study for SAR443820 in Participants With Amyotrophic Lateral Sclerosis (ALS) - Mayo Clinic

    Clinical Trials · Phase 2 Study for SAR443820 in Participants With Amyotrophic Lateral Sclerosis (ALS) · More about research at Mayo Clinic · Mayo Clinic Footer.

  6. Radicava® (Edaravone) Biomarker Study in Participants with Amyotrophic Lateral Sclerosis - Mayo Clinic

    Radicava® (Edaravone) Biomarker Study in Participants with Amyotrophic Lateral Sclerosis · Overview · Participation eligibility · Participating Mayo Clinic ...

  7. Meralgia paresthetica - Diagnosis and treatment - Mayo Clinic

    Pain relief achieved from anesthetic injection into your thigh where the lateral femoral cutaneous nerve enters into it can confirm that you have meralgia ...

  8. A Trial to Evaluate the Efficacy and Safety of Reldesemtiv in Patients with Amyotrophic Lateral Sclerosis (ALS) - Mayo Clinic

    The purpose of this study is to assess the effect of Reldesemtiv versus placebo on functional outcomes in Amyotrophic Lateral Sclerosis (ALS). Participation ...

  9. New myelography protocol helps localize cerebrospinal fluid leaks - Mayo Clinic

    Lateral decubitus DSM at Mayo Clinic has a high diagnostic yield for finding the exact location of a CSF leak. A retrospective study published in Neurology in ...

  10. A Study of New Outcome Measures to Assess the Progression of Amyotrophic Lateral Sclerosis - Mayo Clinic

    The purpose of this study is to evaluate and rank-order a set of new outcome measures administered to patients with amyotrophic lateral sclerosis (ALS), in ...